General Anesthesia Drugs Market
Market Insights on General Anesthesia Drugs covering sales outlook, demand forecast & up-to-date key trends
General Anesthesia Drugs Market By Drug Class (Propofol, Sevoflurane, Dexmedetomidine, Desflurane, Remifentanil, Midazolam), Route of Administration (Intravenous Anesthesia, Inhaled Anesthesia), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) & Region - Forecast 2019 - 2029
GENERAL ANAESTHESIA DRUGS MARKET - KEY RESEARCH FINDINGS
- The global general anaesthesia drugs market size in 2018 was ~US$ 4.2 Bn.
- The general anaesthesia drugs market is expected to grow at a CAGR of ~3% during the forecast period of 2019-2029.
- General anaesthesia drugs are widely used in several surgeries, and increase in the number of cardiovascular and other diseases is expected to fuel the growth of the general anaesthesia drugs market. Moreover, the availability of technologically advanced drug delivery devices and the development of specific targeted drugs is likely to foster the growth of the general anaesthesia drugs market. In addition, the proliferating general anaesthesia drugs portfolio and the number of clinical trials for the development of general anaesthesia drugs with respect to specific indications is expected to foster substantial revenue generation in the general anaesthesia drugs market.
- Collectively, North America and Europe are likely to contribute a significant share in the general anaesthesia drugs market by the end of 2029.
- North America continues to be a prominent regional market for general anaesthesia drugs manufacturers owing to an increase in the adoption of novel therapeutics as well as the launch of new general anaesthesia drugs into the market.
- Europe has also witnessed significant growth in the general anaesthesia drugs market owing to an increasing number of surgeries and the rising demand for the latest technologies and healthcare facilities.
- East Asia is likely to witness growth in the general anaesthesia drugs market due to increasing disposable income and the emergence of several cost-effective generic drugs.
- Propofol is expected to remain a prominent drug class segment in the general anaesthesia drugs market.
- Due to its lipophilic nature and rapid onset of action with minimal side effects, the general anaesthesia drug Propofol is highly preferred for surgeries.
Let us know your requirement to get
100% FREE customization
KEY FACTORS SHAPING THE GENERAL ANAESTHESIA DRUGS MARKET
- Increasing Demographic Trends in the Geriatric Population to Boost the General Anaesthesia Drugs Market
People aged 65 years and above are more prone to chronic diseases, due to which they are likely to require a larger number of procedures. According to a Population Reference Bureau report in 2016, the number of Americans aged 65 and above is projected to be 98 million by 2060, and the group share of the elderly population from the total population is estimated to be nearly 24%. Moreover, the increasing burden of cardiovascular diseases that require surgeries is fuelling the growth of the general anaesthesia drugs market.
In addition, the increasing frequency of co-morbidities among the aging population increases the risk of toxicities and surgical complications related with general anaesthetics. The rising population and increase in the number of procedures that require anaesthesia are some of the factors that are likely to spur the growth of the general anaesthesia drugs market.
- Rising Utilization of Anaesthesia Drugs for Outpatient Procedures to Contribute Significantly to the Growth of the General Anaesthesia Drugs Market
Ambulatory anaesthesia provides rapid recovery from general anaesthesia drugs, which leads to the early discharge of patients and, at the same time, provides several benefits to healthcare providers, patients, as well as third-party payers and hospitals. The number of ambulatory surgeries has been increasing at an alarming rate due to continuous improvements in general anaesthesia drugs & related techniques, and the easy availability of short-acting anaesthetics with minimal side effects. Moreover, appropriate discharge criteria and the availability of minimal invasive surgical techniques has led to an increase in the adoption of ambulatory surgeries.
Furthermore, an increasing number of minimally invasive diagnostic and surgical procedures that are performed on an outpatient basis require a large number of general anaesthesia drugs. General anaesthesia drugs have the potential to impact on the efficacy as well as the cost of care in these outpatient settings. Thus, the general anaesthesia drugs market is estimated to register significant growth due to an increase in the number of surgeries performed in outpatient settings.
- Rising Launch of New Anaesthetic Drugs Expected to Propel the Growth of the General Anaesthesia Drugs Market
Manufacturers are focusing on the launch of new anaesthetic drugs. For instance, Vétoquinol, in collaboration with Jurox Pty. Ltd., will soon launch a new injectable anaesthetic. Manufacturers are also engaged in entering into various collaboration and licensing agreements to ensure the global availability of their products. Collaboration partners seek regulatory approval for the launch and commercialisation of their products in different geographies.
For instance, in September 2017, AstraZeneca and Aspen announced that they have entered into an agreement for the remaining rights to anaesthetics medicines. Moreover, various manufacturers aim at expanding and accelerating their pipeline drugs portfolio for the launch of new general anaesthesia drugs into the market.
For instance, Paion UK Ltd.’s lead candidate, Remimazolam (CNS7056), which is an intravenous general anaesthesia drugs, has submitted an NDA filing in 2018. Thus, rising research and development and the launch of new drugs is expected to significantly drive the general anaesthetic drugs market.
Surgical Complexities and Patient Safety Expectations to Drive New Developments
The migration of health care systems from ‘fee-for-service (FFS)’ to ‘pay-for-performance (P4P)’ models have been forcing the healthcare professionals to reevaluate how they approach the delivery of care. Over the years, a large number of intravenous and inhalation agents of general anesthesia drugs have been introduced, and in parallel various drugs have undergone clinical usage and then withdrawn when found unreliable.
The development of safer drugs were propelled by increasing surgical complexity and severity of patient illness along with growing expectations of patient safety. As general anesthesia drugs are commonly associated with several side effects, manufacturers are directing their investments towards the development of new formulations of existing agents or entirely new chemical entities in strides to improve safety, efficacy, recovery profile, and minimize side effects.
Considering the nature of the product, manufacturers are constantly focusing on keeping up with several regulations and guidelines on general anesthesia drugs which have been revised and updated to improve procedural safety and efficacy. Although the robotic or minimally invasive surgeries have significantly transformed the operational procedures, these processes can take longer than open surgery which may increase the possible risks of anesthesia, thereby compelling manufacturers to innovate their products with reduced side effects.
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystThe U.S. Takes the Center Stage
Despite many advancements in anesthesia techniques and availability of newer and safer drugs, much more scientific exploration and large clinical trials are needed to provide the greatest level of evidence and safety, prior to widespread clinical implementation.
Growth prospects of the general anesthesia drugs market are relatively high in the U.S., driven by increasing risk of organ failures and cardiac diseases among baby boomers along with significant restructuring of the healthcare system in the country. Rapid adoption of innovative business models focused on novel strategies such as seeking faster approval of drugs for reduced time-to-market and more reliance on external partners, academia, and industry consortia will continue to favor the manufacturers operating in the nation.
Tracking the Lasting Effects of General Anesthesia Drugs on Human Health
Although the introduction of general anesthesia drugs dates back to 1840s, they continue to associate with several side effects including elevation in blood pressure and heart rate, respiratory depression, amnesia, and even hallucinations. For example, opioid-containing anesthesia has been linked with post-surgery nausea, vomiting, and drowsiness that can hinder the patient’s recovery.
A focus on opioid-free general anesthesia, aligning with clinical strategies that include the use of multimodal analgesia and enhanced recovery after surgery (ERAS) initiatives, has been making a headway in reducing the use of addictive medications prior to surgical interventions.
Modern general anesthesia drugs have not only enabled complex surgical procedures to be performed safely on patients but also has significantly advanced human medicine. However, several studies regarding the impact of general anesthesia drugs on human health are still underway. The jury is still out as a new Israeli study links child born via C-section under general anesthesia with the risk of developing autism, while another study claims that general anesthesia in infancy has no detectable impact on brain development.
GENERAL ANESTHESIA DRUGS MARKET TAXONOMY
The global general anesthesia drugs market is segmented in detail to cover every aspect of the market and present a complete market intelligence approach to the reader.
By Drug Class
- Propofol
- Sevoflurane
- Dexmedetomidine
- Desflurane
- Remifentanil
- Midazolam
- Others
- (Others – Sufentanil, Fentanyl, Ketamine, Isoflurane, Thiopental etc.)
By Route of Administration
- Intravenous Anesthesia
- Inhaled Anesthesia
By End User
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
By Region
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- MEA
An unified Market Research Subscription Platform, built for today’s disparate research needs.
Frequently Asked Questions
The general anaesthesia drugs market is likely to record a CAGR of 3% through 2032.
The general anaesthesia drugs market size is estimated to cross US$ 6.35 Bn by 2032.
North America and Europe are likely to lead the general anaesthesia drugs market.
The general anaesthesia drugs market is likely to record a value of US$ 4.73 Bn in 2022.
Table of Content
1. Executive Summary
1.1. Global Market Outlook
1.2. Demand Side Trends
1.3. Supply Side Trends
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Key Market Trends
4. Key Success Factors
4.1. Reimbursement Guidelines for Anesthesia Drugs
4.2. Pipeline Analysis of Anesthesia Drugs
5. Global General Anesthesia Drugs Market Demand (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
5.2.1. Y-o-Y Growth Trend Analysis
5.2.2. Absolute $ Opportunity Analysis
6. Market Background
6.1. Macro-Economic Factors
6.1.1. Rising of Geriatric Population
6.1.2. Cost of healthcare expenditure
6.2. Forecast Factors - Relevance & Impact
6.2.1. Increasing number of surgeries
6.2.2. New approval of anesthesia drugs
6.2.3. R&D investment by major players
6.3. Market Dynamics
6.3.1. Drivers
6.3.2. Restraints
6.3.3. Opportunity Analysis
7. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Drug Class
7.1. Introduction / Key Findings
7.2. Historical Market Size (US$ Mn) and Analysis By Drug Class, 2014 - 2018
7.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Drug Class, 2019 - 2029
7.3.1. Propofol
7.3.2. Sevoflurane
7.3.3. Dexmedetomidine
7.3.4. Desflurane
7.3.5. Remifentanil
7.3.6. Midazolam
7.3.7. Others
7.4. Market Attractiveness Analysis By Drug Class
8. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Route of Administration
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Mn) and Analysis By Route of Administration, 2014 - 2018
8.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By Route of Administration, 2019- 2029
8.3.1. Intravenous Anesthesia
8.3.2. Inhaled Anesthesia
8.4. Market Attractiveness Analysis By Route of Administration
9. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by End User
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Mn) and Analysis By End User, 2014 - 2018
9.3. Current and Future Market Size (US$ Mn) and Analysis and Forecast By End User, 2019 - 2029
9.3.1. Hospitals
9.3.2. Speciality Clinics
9.3.3. Ambulatory Surgical Centers
9.4. Market Attractiveness Analysis By End User
10. Global General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Region
10.1. Introduction
10.2. Historical Market Size (US$ Mn) and Analysis By Region, 2014 - 2018
10.3. Current Market Size (US$ Mn) and Analysis and Forecast By Region, 2019 - 2029
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. South Asia
10.3.5. East Asia
10.3.6. Oceania
10.3.7. Middle East and Africa
10.4. Market Attractiveness Analysis By Region
11. North America General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
11.1. Introduction
11.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
11.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
11.3.1. By Country
11.3.1.1. U.S.
11.3.1.2. Canada
11.3.2. By Drug Class
11.3.3. By Route of Administration
11.3.4. By End User
11.4. Market Attractiveness Analysis
11.4.1. By Country
11.4.2. By Drug Class
11.4.3. By Route of Administration
11.4.4. By End User
11.5. Drivers and Restraints - Impact Analysis
12. Latin America General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
12.1. Introduction
12.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
12.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
12.3.1. By Country
12.3.1.1. Brazil
12.3.1.2. Mexico
12.3.1.3. Rest of Latin America
12.3.2. By Drug Class
12.3.3. By Route of Administration
12.3.4. By End User
12.4. Market Attractiveness Analysis
12.4.1. By Country
12.4.2. By Drug Class
12.4.3. By Route of Administration
12.4.4. By End User
12.5. Drivers and Restraints - Impact Analysis
13. Europe General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
13.1. Introduction
13.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
13.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
13.3.1. By Country
13.3.1.1. Germany
13.3.1.2. Italy
13.3.1.3. France
13.3.1.4. U.K.
13.3.1.5. Spain
13.3.1.6. BENELUX
13.3.1.7. Russia
13.3.1.8. Rest of Europe
13.3.2. By Drug Class
13.3.3. By Route of Administration
13.3.4. By End User
13.4. Market Attractiveness Analysis
13.4.1. By Country
13.4.2. By Drug Class
13.4.3. By Route of Administration
13.4.4. By End User
13.5. Drivers and Restraints - Impact Analysis
14. South Asia General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
14.1. Introduction
14.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
14.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
14.3.1. By Country
14.3.1.1. India
14.3.1.2. Thailand
14.3.1.3. Indonesia
14.3.1.4. Malaysia
14.3.1.5. Rest of South Asia
14.3.2. By Drug Class
14.3.3. By Route of Administration
14.3.4. By End User
14.4. Market Attractiveness Analysis
14.4.1. By Country
14.4.2. By Drug Class
14.4.3. By Route of Administration
14.4.4. By End User
14.5. Drivers and Restraints - Impact Analysis
15. East Asia General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
15.1. Introduction
15.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
15.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
15.3.1. By Country
15.3.1.1. China
15.3.1.2. Japan
15.3.1.3. South Korea
15.3.2. By Drug Class
15.3.3. By Route of Administration
15.3.4. By End User
15.4. Market Attractiveness Analysis
15.4.1. By Country
15.4.2. By Drug Class
15.4.3. By Route of Administration
15.4.4. By End User
15.5. Drivers and Restraints - Impact Analysis
16. Oceania General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
16.1. Introduction
16.2. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
16.3. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
16.3.1. By Country
16.3.1.1. Australia
16.3.1.2. New Zealand
16.3.2. By Drug Class
16.3.3. By Route of Administration
16.3.4. By End User
16.4. Market Attractiveness Analysis
16.4.1. By Country
16.4.2. By Drug Class
16.4.3. By Route of Administration
16.4.4. By End User
16.5. Drivers and Restraints - Impact Analysis
17. Middle East and Africa General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
17.1. Introduction
17.2. Pricing Analysis
17.3. Historical Market Size (US$ Mn) and Trend Analysis By Market Taxonomy, 2014 - 2018
17.4. Market Size (US$ Mn) and Forecast By Market Taxonomy, 2019 - 2029
17.4.1. By Country
17.4.1.1. GCC Countries
17.4.1.2. Turkey
17.4.1.3. Northern Africa
17.4.1.4. South Africa
17.4.1.5. Rest of Middle East and Africa
17.4.2. By Drug Class
17.4.3. By Route of Administration
17.4.4. By End User
17.5. Market Attractiveness Analysis
17.5.1. By Country
17.5.2. By Drug Class
17.5.3. By Route of Administration
17.5.4. By End User
17.6. Drivers and Restraints - Impact Analysis
18. Emerging Countries General Anesthesia Drugs Market Analysis 2014-2018 and Forecast 2019-2029
18.1. Introduction
18.1.1. Global Vs. Country Growth Comparison
18.2. Brazil General Anesthesia Drugs Market Analysis
18.2.1. Introduction
18.2.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.2.2.1. By Drug Class
18.2.2.2. By Route of Administration
18.2.2.3. By End User
18.3. Drivers and Restraints - Impact Analysis
18.4. China General Anesthesia Drugs Market Analysis
18.4.1. Introduction
18.4.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.4.2.1. By Drug Class
18.4.2.2. By Route of Administration
18.4.2.3. By End User
18.5. Drivers and Restraints - Impact Analysis
18.6. India General Anesthesia Drugs Market Analysis
18.6.1. Introduction
18.6.2. Market Value (US$ Mn) Analysis and Forecast by Market Taxonomy
18.6.2.1. By Drug Class
18.6.2.2. By Route of Administration
18.6.2.3. By End User
18.7. Drivers and Restraints - Impact Analysis
19. Competition Analysis
19.1. Competition Dashboard
19.2. Competition Deep Dive
19.2.1. Baxter International Inc.
19.2.1.1. Overview
19.2.1.2. Key Financials
19.2.1.3. Profitability by Market Segments (Product/Channel/Region)
19.2.1.4. Key Development
19.2.1.5. Strategy Overview
19.2.1.5.1. Marketing Strategy
19.2.1.5.2. Product Strategy
19.2.1.5.3. Channel Strategy
19.2.2. AstraZeneca
19.2.2.1. Overview
19.2.2.2. Key Financials
19.2.2.3. Profitability by Market Segments (Product/Channel/Region)
19.2.2.4. Key Development
19.2.2.5. Strategy Overview
19.2.2.5.1. Marketing Strategy
19.2.2.5.2. Product Strategy
19.2.2.5.3. Channel Strategy
19.2.3. AbbVie Inc.
19.2.3.1. Overview
19.2.3.2. Key Financials
19.2.3.3. Profitability by Market Segments (Product/Channel/Region)
19.2.3.4. Key Development
19.2.3.5. Strategy Overview
19.2.3.5.1. Marketing Strategy
19.2.3.5.2. Product Strategy
19.2.3.5.3. Channel Strategy
19.2.4. B. Braun Melsungen AG
19.2.4.1. Overview
19.2.4.2. Key Financials
19.2.4.3. Profitability by Market Segments (Product/Channel/Region)
19.2.4.4. Key Development
19.2.4.5. Strategy Overview
19.2.4.5.1. Marketing Strategy
19.2.4.5.2. Product Strategy
19.2.4.5.3. Channel Strategy
19.2.5. Fresenius SE & Co. KgaA
19.2.5.1. Overview
19.2.5.2. Key Financials
19.2.5.3. Profitability by Market Segments (Product/Channel/Region)
19.2.5.4. Key Development
19.2.5.5. Strategy Overview
19.2.5.5.1. Marketing Strategy
19.2.5.5.2. Product Strategy
19.2.5.5.3. Channel Strategy
19.2.6. Pfizer
19.2.6.1. Overview
19.2.6.2. Key Financials
19.2.6.3. Profitability by Market Segments (Product/Channel/Region)
19.2.6.4. Key Development
19.2.6.5. Strategy Overview
19.2.6.5.1. Marketing Strategy
19.2.6.5.2. Product Strategy
19.2.6.5.3. Channel Strategy
20. Assumptions and Acronyms Used
21. Research Methodology
Let us know your requirement to get
100% FREE customization
List of Tables
Table 01: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 02: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 03: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 04: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Region
Table 05: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 06: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 07: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 08: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 09: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 10: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 11: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 12: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 13: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 14: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 15: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 16: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 17: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 18: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 19: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 20: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 21: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 22: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 23: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 24: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 25: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 26: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 27: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 28: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 29: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Country
Table 30: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 31: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 32: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 33: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 34: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 35: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 36: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 37: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 38: China General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Table 39: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Product Type
Table 40: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By Route of Administration
Table 41: India General Anesthesia Drugs Market Size (US$ Mn) Analysis 2014-2018 and Forecast 2019-2029, By End User
Find your sweet spots for generating winning opportunities in this market.
Talk to AnalystList of Charts
Figure 01: Global General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 02: Global General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 03: Global General Anesthesia Drugs Market Absolute $ Opportunity, 2019–2029
Figure 04: General Anesthesia Drugs Market Forecast Factors – Relevance and Impact
Figure 05: Global General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 06: Global General Anesthesia Drugs Market Y-o-Y Growth Projections by Product Type, 2019 – 2029
Figure 07: Global General Anesthesia Drugs Market Analysis by Product type–2019 & 2029
Figure 08: Global General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 09: Global General Anesthesia Drugs Market Y-o-Y Growth Projections Route of Administration, 2019 – 2029
Figure 10: Global General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 11: Global General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 12: Global General Anesthesia Drugs Market Y-o-Y Growth Projections End User, 2019 – 2029
Figure 13: Global General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 14: Global General Anesthesia Drugs Market Analysis by Region–2019 & 2029
Figure 15: Global General Anesthesia Drugs Market Y-o-Y Growth Projections Region, 2019 – 2029
Figure 16: Global General Anesthesia Drugs Market Analysis by Region–2019 & 2029
Figure 17: North America General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 18: North America General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 19: North America General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 20: North America General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 21: North America General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 22: North America General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 23: Latin America General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 24: Latin America General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 25: Latin America General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 26: Latin America General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 27: Latin America General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 28: Latin America General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 29: Europe General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 30: Europe General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 31: Europe General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 32: Europe General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 33: Europe General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 34: Europe General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 35: South Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 36: South Asia General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 37: South Asia General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 38: South Asia General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 39: South Asia General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 40: South Asia General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 41: East Asia General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 42: East Asia General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 43: East Asia General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 44: East Asia General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 45: East Asia General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 46: East Asia General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 47: Oceania General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 48: Oceania General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 49: Oceania General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 50: Oceania General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 51: Oceania General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 52: Oceania General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 53: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 54: Middle East and Africa General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 55: Middle East and Africa General Anesthesia Drugs Market Analysis by Country–2019 & 2029
Figure 56: Middle East and Africa General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 57: Middle East and Africa General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 58: Middle East and Africa General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 59: Emerging Countries Market Value Share (2019)
Figure 60: Emerging Countries General Anesthesia Drugs Market Value (US$ Mn), By Key Countries, 2019-2029
Figure 61: Brazil General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 62: Brazil General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 63: Brazil General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 64: Brazil General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 65: Brazil General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 66: China General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 67: China General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 68: China General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 69: China General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 70: China General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Figure 71: India General Anesthesia Drugs Market Size (US$ Mn) Analysis, 2014–2018
Figure 72: India General Anesthesia Drugs Market Size (US$ Mn) & Y-o-Y Growth (%), 2019–2029
Figure 73: India General Anesthesia Drugs Market Analysis by Product Type–2019 & 2029
Figure 74: India General Anesthesia Drugs Market Analysis by Route of Administration–2019 & 2029
Figure 75: India General Anesthesia Drugs Market Analysis by End User–2019 & 2029
Need specific information?
Request CustomizationExplore Healthcare Insights
View Reports
